
Dr. Reddy’s Q1 net slides 36% on impairment charge
The Hindu
Drugmaker sets aside Rs. 193 crore after losing U. S. arbitration case
Pharma major Dr. Reddy’s Laboratories on Tuesday reported that the first-quarter consolidated net profit declined by 36% to Rs.380.4 crore, from Rs.594.6 crore in the earlier period of the year. Revenue from operations rose almost by 12% to Rs.4,945.1 Crore in the three months ending in June (Rs.4,426.5 crore), with net sales also increasing by a similar extent to Rs.4,826.2 crore (Rs.4,324.4 crore). Total income at Rs.5,053 crore (Rs.4,513.6 crore) was an increase of almost 12%, according to the results prepared as per Indian Accounting Standards (Ind A. S).More Related News